e-learning
resources
Stockholm 2007
Sunday 16.09.2007
Considerations in the management of idiopathic pulmonary fibrosis and other interstitial lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Statin-induced infiltrative lung disease. A series of 10 patients
A. Jibbaoui, P. Bonniaud, G. Jolimoy, C. Camus, P. Camus (Dijon, France)
Source:
Annual Congress 2007 - Considerations in the management of idiopathic pulmonary fibrosis and other interstitial lung diseases
Session:
Considerations in the management of idiopathic pulmonary fibrosis and other interstitial lung diseases
Session type:
Thematic Poster Session
Number:
809
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Jibbaoui, P. Bonniaud, G. Jolimoy, C. Camus, P. Camus (Dijon, France). Statin-induced infiltrative lung disease. A series of 10 patients. Eur Respir J 2007; 30: Suppl. 51, 809
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Panel discussion: What’s NEW in the 2022 ERS/ATS PFT Interpretation Statement
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Autopsy findings in 42 consecutive patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2008; 32: 170-174
Year: 2008
UIP-like or NSIP pattern in interstitial lung disease patients (ILD), following by ‘connective tissue disease ‘(CTD)
Source: Annual Congress 2012 - Diffuse parenchymal lung disease III
Year: 2012
Drug-induced infiltrative lung disease
Source: Eur Respir J 2001; 18: 93S-100S
Year: 2001
Drug-induced infiltrative lung disease
Source: Eur Respir Mon; 2009: 46: 287–318
Year: 2009
Clinical and molecular analysis of lung cancer associated with fibrosing and diffuse interstitial lung disease.
Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer
Year: 2021
Clinical characteristics of 30 patients with interstitial pneumonia associated with anti-aminoacyl-tRNA-synthetase antibodies
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
Tumour infiltrating lymphocytes and tumour associated macrophages in chronic obstructive pulmonary disease (COPD) patients with non-small cell lung cancer (NSCLC) and in patients with NSCLC
Source: Eur Respir J 2005; 26: Suppl. 49, 92s
Year: 2005
The prevalence of bronchogenic lung cancer (BLC) in patients with idiopathic pneumonic fibrosis (IPF)
Source: Eur Respir J 2003; 22: Suppl. 45, 250s
Year: 2003
The clinical value of surgical lung biopsy in 166 patients with suspected interstitial lung disease
Source: International Congress 2015 – New insights into IIPs
Year: 2015
Antisynthetase syndrome (AS) in patients with diffuse interstitial lung disease (ILD)
Source: International Congress 2015 – Connective tissue disorders
Year: 2015
A multicentre evaluation of inter-multidisciplinary team agreement for diagnosis in diffuse lung disease
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016
A case series study on re-treatment to lung cancer after drug-induced interstitial lung disease
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Year: 2018
Interstitial lung disease in patients with connective tissue diseases - a report of 3 cases
Source: Eur Respir J 2004; 24: Suppl. 48, 668s
Year: 2004
Predictors of mortality and risk prediction among patients with scleroderma related interstitial lung disease
Source: International Congress 2015 – IPF: clinical aspects II
Year: 2015
Depiction of malignancy in patients with diffuse interstitial lung disease (DILD) presenting with nodular opacities
Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease
Year: 2008
A study on chemotherapy induced interstitial lung disease in patients with unresectable non-small cell lung cancer complicated by combined pulmonary fibrosis and emphysema
Source: Annual Congress 2012 - Treatment of lung cancer
Year: 2012
Study of factors affecting mortality in ILD cases over 2 years
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Pattern and impact of rheumatology referral in patients with ILD and autoimmune features
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
A multicentre evaluation of inter-multidisciplinary team agreement for predicted disease behaviour and management strategy in diffuse lung disease
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept